TMPRSS2 and acute myeloid leukemia: Highly immunogenic neoantigens produced by TMPRSS2::ERG2 in pancreatic cancer, DEK::AFF2 in metastatic head and neck cancer, and CBFB::MYH11 in acute myeloid leukemia have been used to generate neoantigen-reactive T-cells.